Download FREE Report Sample
Download Free sampleItraconazole (Sporanox), a new generation of triazole, is a highly effective broad-spectrum antifungal drug that can inhibit the synthesis of ergosterol by combining with fungal cytochrome P450 isoenzyme.This product is effective for tinea dermatia, candida, cryptococcus neoforme, choridia spore, aspergillus, histoplasmosis, paracardium brasileum, schencosporium, fungi, mycoderma, dermatitis spore, etc.
Sporanox Market contains market size and forecasts of Sporanox in Global, including the following market information:
Global Sporanox Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sporanox market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sporanox include Abbott, Johnson & Johnson, Smilax, Ultratech India, Nifty Labs, Nosch Labs, Shouguang Fukang Pharmaceutical, Lepu Pharmaceuticals and Harbin Sanlian Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sporanox companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sporanox Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sporanox Market Segment Percentages, by Type, 2021 (%)
Injection
Solution
Tablets
Capsule
Granules
Global Sporanox Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sporanox Market Segment Percentages, by Application, 2021 (%)
Yeast Disease
Histoplasmosis
Ringworm Of The Nails
Systemic Infection
Global Sporanox Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sporanox Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sporanox revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sporanox revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Johnson & Johnson
Smilax
Ultratech India
Nifty Labs
Nosch Labs
Shouguang Fukang Pharmaceutical
Lepu Pharmaceuticals
Harbin Sanlian Pharmaceutical
Kangzhi Pharmaceutical
Shanghai Modern Hasen Pharmaceutical
Lepu Pharmaceutical
Tianjin Lisheng Pharmaceutical
Chengdu Beite Pharmaceutical
Xi'an Yangsen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy